CellaVision AB (STU:C26)
€ 18.64 0.88 (4.95%) Market Cap: 454.18 Mil Enterprise Value: 445.31 Mil PE Ratio: 33.07 PB Ratio: 6.46 GF Score: 99/100

Q4 2023 CellaVision AB Earnings Call Transcript

Feb 07, 2024 / 10:00AM GMT
Release Date Price: €19.46 (+13.01%)
Operator

This call is being recorded. Welcome to CellaVision Q4 report 2023. (Operator Instructions) Now I will hand the conference over to CEO, Simon Ostergaard. Please go ahead.

Simon Ostergaard
CellaVision AB - President & CEO

Thank you very much, and thank you everybody for dialing in to our conference call. So, this is CellaVision's Q4 report that we will present today. And that, of course, also includes the aggregated numbers from the entire 2023. I have our CFO, Magnus Blixt with me, and we will be very pleased to have a conversation and answer any questions you may have after my presentation.

So, let's start with the quarter in brief. 2023 really started with sort of the same macroeconomic challenges, as when we lift the second quarter of 2022. So, that was a little bit of an uphill battle. Then throughout the year, we have seen the inventory adjustments level out, and we have sort of had increased demand for our offerings, which has been seen both in a reasonable Q2 to the best of our belief at a pretty good Q3, given the fact that Q3 typically is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot